Advertisement
TAK vs TKPHF
To understand the difference between Takeda Pharmaceutical Co - ADR (TAK) vs. Takeda Pharmaceutical Co (TKPHF) it is enough to know the definitions of ADR
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TAK’s FA Score shows that 2 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).
- TAK’s FA Score: 2 green, 3 red.
- TKPHF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TAK’s TA Score shows that 7 TA indicator(s) are bullish while TKPHF’s TA Score has 7 bullish TA indicator(s).
- TAK’s TA Score: 7 bullish, 3 bearish.
- TKPHF’s TA Score: 7 bullish, 2 bearish.
Price Growth
TAK (@Pharmaceuticals: Generic) experienced а +2.74% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +11.86% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.
Reported Earning Dates
TAK is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Pharmaceuticals: Generic (+0.10% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
| TAK | TKPHF | TAK / TKPHF | |
| Capitalization | 48.8B | 48.8B | 100% |
| EBITDA | 1.13T | 1.13T | 100% |
| Gain YTD | 16.314 | 14.784 | 110% |
| P/E Ratio | 53.30 | 53.14 | 100% |
| Revenue | 4.48T | 4.48T | 100% |
| Total Cash | 419B | 419B | 100% |
| Total Debt | 4.51T | 4.51T | 100% |
TAK | TKPHF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 26 | 36 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 96 | 100 | |
SMR RATING 1..100 | 88 | 88 | |
PRICE GROWTH RATING 1..100 | 53 | 74 | |
P/E GROWTH RATING 1..100 | 33 | 34 | |
SEASONALITY SCORE 1..100 | 65 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TAK's Valuation (6) in the Pharmaceuticals Major industry is in the same range as TKPHF (6) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.
TAK's Profit vs Risk Rating (96) in the Pharmaceuticals Major industry is in the same range as TKPHF (100) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.
TAK's SMR Rating (88) in the Pharmaceuticals Major industry is in the same range as TKPHF (88) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.
TAK's Price Growth Rating (53) in the Pharmaceuticals Major industry is in the same range as TKPHF (74) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.
TAK's P/E Growth Rating (33) in the Pharmaceuticals Major industry is in the same range as TKPHF (34) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.
| TAK | TKPHF | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 57% | 1 day ago 48% |
| Stochastic ODDS (%) | 1 day ago 43% | 1 day ago 48% |
| Momentum ODDS (%) | 1 day ago 32% | 1 day ago 42% |
| MACD ODDS (%) | 1 day ago 46% | 1 day ago 58% |
| TrendWeek ODDS (%) | 1 day ago 40% | 1 day ago 46% |
| TrendMonth ODDS (%) | 1 day ago 36% | 1 day ago 42% |
| Advances ODDS (%) | 1 day ago 42% | 15 days ago 39% |
| Declines ODDS (%) | 10 days ago 45% | N/A |
| BollingerBands ODDS (%) | 1 day ago 50% | 1 day ago 58% |
| Aroon ODDS (%) | 1 day ago 36% | 1 day ago 51% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RMMZ | 14.69 | 0.24 | +1.64% |
| RiverNorth Managed Duration Municipal Income Fund II | |||
| GSIE | 40.78 | 0.15 | +0.37% |
| Goldman Sachs ActiveBeta® Intl Eq ETF | |||
| CAOS | 89.61 | 0.15 | +0.17% |
| Alpha Architect Tail Risk ETF | |||
| INTW | 22.07 | -0.19 | -0.85% |
| GraniteShares 2x Long INTC Daily ETF | |||
| SRS | 46.65 | -0.88 | -1.86% |
| ProShares UltraShort Real Estate | |||
TAK and
Correlation & Price change
A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.
| Ticker / NAME | Correlation To TAK | 1D Price Change % | ||
|---|---|---|---|---|
| TAK | 100% | +0.72% | ||
| HLN - TAK | 42% Loosely correlated | -0.41% | ||
| SGIOY - TAK | 41% Loosely correlated | +2.98% | ||
| ESAIY - TAK | 35% Loosely correlated | +2.66% | ||
| BNXTF - TAK | 32% Poorly correlated | +2.55% | ||
| ZTS - TAK | 29% Poorly correlated | +0.08% | ||
More | ||||
TKPHF and
Correlation & Price change
A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.
| Ticker / NAME | Correlation To TKPHF | 1D Price Change % | ||
|---|---|---|---|---|
| TKPHF | 100% | +11.86% | ||
| TAK - TKPHF | 27% Poorly correlated | +0.72% | ||
| TEVJF - TKPHF | 17% Poorly correlated | N/A | ||
| ZTS - TKPHF | 16% Poorly correlated | +0.08% | ||
| BHC - TKPHF | 15% Poorly correlated | +1.94% | ||
| QNTM - TKPHF | 13% Poorly correlated | -1.64% | ||
More | ||||